Biblio
Found 86 results
Author Keyword Title Type [ Year] Filters: First Letter Of Keyword is F [Clear All Filters]
“Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.
, “Rarity of the Alzheimer disease-protective APP A673T variant in the United States.”, JAMA Neurol, vol. 72, no. 2, pp. 209-16, 2015.
, “Cohort Profile: the Health and Retirement Study (HRS).”, Int J Epidemiol, vol. 43, no. 2, pp. 576-85, 2014.
, “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.
, “An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.”, PLoS Genet, vol. 10, no. 3, p. e1004211, 2014.
, “Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.”, BMC Res Notes, vol. 7, p. 42, 2014.
, “Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.”, PLoS Genet, vol. 10, no. 10, p. e1004758, 2014.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “Alzheimer's disease: analyzing the missing heritability.”, PLoS One, vol. 8, no. 11, p. e79771, 2013.
, “Alzheimer's disease risk genes and the age-at-onset phenotype.”, Neurobiol Aging, vol. 34, no. 11, pp. 2696.e1-5, 2013.
, “Exceptional memory performance in the Long Life Family Study.”, Neurobiol Aging, vol. 34, no. 11, pp. 2445-8, 2013.
, “Exceptional memory performance in the Long Life Family Study.”, Neurobiol Aging, vol. 34, no. 11, pp. 2445-8, 2013.
, “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.
, “HAMR: high-throughput annotation of modified ribonucleotides.”, RNA, vol. 19, no. 12, pp. 1684-92, 2013.
, “Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.”, Nat Genet, vol. 45, no. 12, pp. 1452-8, 2013.
, “Genome-wide association analysis of age-at-onset in Alzheimer's disease.”, Mol Psychiatry, vol. 17, no. 12, pp. 1340-6, 2012.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “Overview and findings from the religious orders study.”, Curr Alzheimer Res, vol. 9, no. 6, pp. 628-45, 2012.
, “Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.”, Neurobiol Aging, vol. 32, no. 12, pp. 2113-22, 2011.
, “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “A comprehensive genetic association study of Alzheimer disease in African Americans.”, Arch Neurol, vol. 68, no. 12, pp. 1569-79, 2011.
, “Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.”, Hum Mol Genet, vol. 19, no. 10, pp. 2068-78, 2010.
, “Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.”, PLoS Genet, vol. 6, no. 9, p. e1001130, 2010.
, “Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.”, PLoS Genet, vol. 6, no. 9, p. e1001130, 2010.
,